Literature DB >> 13880420

Extrapyramidal side effects and clinical response to the phenothiazines.

J O COLE, D J CLYDE.   

Abstract

Entities:  

Keywords:  EXTRAPYRAMIDAL TRACTS/pharmacology; MENTAL DISORDERS/therapy; PHENOTHIAZINES/therapy

Mesh:

Substances:

Year:  1961        PMID: 13880420

Source DB:  PubMed          Journal:  Rev Can Biol        ISSN: 0035-0915


× No keyword cloud information.
  7 in total

1.  MODIFICATION BY DRUGS OF THE METABOLISM OF 3,4-DIHYDROXYPHENYLETHYLAMINE, NORADRENALINE AND 5-HYDROXYTRYPTAMINE IN THE BRAIN.

Authors:  R LAVERTY; D F SHARMAN
Journal:  Br J Pharmacol Chemother       Date:  1965-06

2.  The interaction of neuroleptic and muscarinic agents with central dopaminergic systems.

Authors:  P H Kelly; R J Miller
Journal:  Br J Pharmacol       Date:  1975-05       Impact factor: 8.739

3.  Anti-dopaminergic and anti-muscarinic effects of dibenzodiazepines: relationship to drug induced Parkinsonism.

Authors:  R J Miller; C R Hiley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

4.  Dopamine receptor blockade by neuroleptic drugs in Aplysia neurones.

Authors:  W D Heiss; J Hoyer
Journal:  Experientia       Date:  1974-11-15

5.  Antipsychotic drugs and dopamine-mediated responses in Aplysia neurons.

Authors:  W D Heiss; J Hoyer; G Thalhammer
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

6.  Dopamine-sensitive adenylate cyclase in mammalian brain: a possible site of action of antipsychotic drugs.

Authors:  Y C Clement-Cormier; J W Kebabian; G L Petzold; P Greengard
Journal:  Proc Natl Acad Sci U S A       Date:  1974-04       Impact factor: 11.205

7.  Effect of drugs used in psychoses on cerebral dopamine metabolism.

Authors:  R O'Keeffe; D F Sharman; M Vogt
Journal:  Br J Pharmacol       Date:  1970-02       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.